shot-button
Ganesh Chaturthi Ganesh Chaturthi
Home > Entertainment News > Bollywood News > Article > Irrfan Khan thanks audience for being part of his journey

Irrfan Khan thanks audience for being part of his journey

Updated on: 27 June,2018 09:13 AM IST  |  Mumbai
mid-day online desk |

Irrfan Khan, who is undergoing treatment in London for a neuroendocrine tumour thanked IIFA for the award in his latest tweet

Irrfan Khan thanks audience for being part of his journey

Irrfan Khan

Irrfan Khan on Tuesday acknowledged the IIFA Best Actor in a leading role Award that he has received for his performance in Hindi Medium, and has thanked the audience for being a part of his journey. Irrfan, who is undergoing treatment in London for a neuroendocrine tumour, tweeted: "Thank you to IIFA and our audience who have been part for my journey."


The International Indian Film Academy (IIFA) Awards ceremony was held in Bangkok on June 24. Irrfan was lauded for his performance as a concerned father in a story which points out how the ability to speak fluent English is ignorantly considered a yardstick to measure sophistication and elitism.



The actor had earlier this month penned a heartfelt letter about how life-changing the disease has been for him, and how it has made him realise "how you are just a cork floating in the ocean with unpredictable currents". His colleagues and friends from the industry have been sending him good wishes and praying for his well-being.

Irrfan Khan's next movie to release will be Karwaan on August 3.

Catch up on all the latest entertainment news and gossip here. Also download the new mid-day Android and iOS apps to get latest updates

Edited by mid-day online desk with inputs from IANS

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK